The association between corticosteroid uses and mortality among severe COVID-19 patients.
作者信息
Tang Hung-Jen, Lai Chih-Cheng
机构信息
Department of Infectious Diseases, Chi-Mei Medical Center, Tainan, Taiwan.
Department of Internal Medicine, Kaohsiung Veterans General Hospital, Tainan Branch, Tainan, Taiwan.
出版信息
J Infect. 2021 Feb;82(2):e24. doi: 10.1016/j.jinf.2020.09.005. Epub 2020 Sep 12.
Abstract
摘要
相似文献
1
The association between corticosteroid uses and mortality among severe COVID-19 patients.
J Infect. 2021 Feb;82(2):e24. doi: 10.1016/j.jinf.2020.09.005. Epub 2020 Sep 12.
2
Corticosteroid Injections and COVID-19 Infection Risk.
Pain Med. 2020 Aug 1;21(8):1703-1706. doi: 10.1093/pm/pnaa199.
3
Corticosteroid use in selected patients with severe acute respiratory distress syndrome related to COVID-19.
J Infect. 2020 Aug;81(2):e89-e90. doi: 10.1016/j.jinf.2020.05.023. Epub 2020 May 14.
4
Contrasting evidence for corticosteroid treatment for coronavirus-induced cytokine storm.
Hong Kong Med J. 2020 Jun;26(3):269-271. doi: 10.12809/hkmj208517. Epub 2020 Jun 5.
5
Pros and cons of corticosteroid therapy for COVID-19 patients.
Respir Physiol Neurobiol. 2020 Sep;280:103492. doi: 10.1016/j.resp.2020.103492. Epub 2020 Jul 10.
6
Corticosteroids in the Management of Pregnant Patients With Coronavirus Disease (COVID-19).
Obstet Gynecol. 2021 Feb 1;137(2):379-380. doi: 10.1097/AOG.0000000000004271.
7
Asthma, biologics, corticosteroids, and coronavirus disease 2019.
Ann Allergy Asthma Immunol. 2020 Jul;125(1):12-13. doi: 10.1016/j.anai.2020.05.001. Epub 2020 May 6.
8
Corticosteroids in the Management of Pregnant Patients With Coronavirus Disease (COVID-19).
Obstet Gynecol. 2021 Feb 1;137(2):378-379. doi: 10.1097/AOG.0000000000004272.
9
Re: Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19.
J Infect. 2020 Aug;81(2):e79-e81. doi: 10.1016/j.jinf.2020.05.004. Epub 2020 May 8.
10
Common concerns in managing bronchial asthma during the COVID-19 pandemic.
Int J Tuberc Lung Dis. 2020 Jul 1;24(7):750-752. doi: 10.5588/ijtld.20.0378.
引用本文的文献
1
Immunomodulatory therapies for the treatment of SARS-CoV-2 infection: an update of the systematic literature review to inform EULAR points to consider.
RMD Open. 2021 Oct;7(3). doi: 10.1136/rmdopen-2021-001899.
2
Efficacy and safety of systematic corticosteroids among severe COVID-19 patients: a systematic review and meta-analysis of randomized controlled trials.
Signal Transduct Target Ther. 2021 Feb 21;6(1):83. doi: 10.1038/s41392-021-00521-7.
本文引用的文献
1
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis.
JAMA. 2020 Oct 6;324(13):1330-1341. doi: 10.1001/jama.2020.17023.
2
Dexamethasone in Hospitalized Patients with Covid-19.
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.
3
The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis.
J Infect. 2020 Jul;81(1):e13-e20. doi: 10.1016/j.jinf.2020.03.062. Epub 2020 Apr 10.
4
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges.
Int J Antimicrob Agents. 2020 Mar;55(3):105924. doi: 10.1016/j.ijantimicag.2020.105924. Epub 2020 Feb 17.
Zotero 插件